What Happened?
, -based Allarity Therapeutics Appointed Alex Epshinsky as Chief Financial Officer
About the Company
Allarity Therapeutics (Nasdaq: ALLR) is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Publicly traded on NASDAQ, Allarity (ALLR) is headquartered in Cambridge, MA, while maintaining an R&D facility in Hoersholm, Denmark. Allarity is committed to enhancing patient outcomes through improved decision-making and personalized cancer care.
About the Person
Alex Epshinsky is Chief Financial Officer at Allarity Therapeutics. Previously, Alex held various senior HR leadership roles in the industry.
Info Source
News
Short Profile